Linda Coleman, JD, General Counsel, Quorum Review IRB, to Present at MAGI East Conference

Share Article

Linda Coleman, JD, CHC, CHRC, Director of Regulatory Affairs & General Counsel, Quorum Review IRB, will present “Good Clinical Practice Essentials: What You Won’t Learn from the Regulations” at MAGI East Clinical Research Conference on Sunday, May 20th, in Arlington, VA.

News Image

Past News Releases

RSS

Linda Coleman, JD, CHC, CHRC, Director of Regulatory Affairs & General Counsel, Quorum Review IRB, will present “Good Clinical Practice Essentials: What You Won’t Learn from the Regulations” at MAGI East Clinical Research Conference on Sunday, May 20th, in Arlington, VA.

With over a decade of legal expertise in clinical trial research and regulatory oversight, Ms. Coleman’s session will provide unique insights into timely GCP topics, including recent guidance from the FDA, inspection and audit findings. Quorum Review representatives will also host a table at the conference to answer questions and discuss Quorum’s central IRB services.

Ms. Coleman joined Quorum Review in 2007 as the Director of Regulatory Affairs. Today she serves that role in addition to the role of General Counsel, which she assumed early in 2011. In April 2012, she was awarded Puget Sound Business Journal’s 2012 Award for Outstanding General Counsel for a Small Company (<1000 employees).

Held in Arlington, Virginia, from May 20-23, with over 600 expected to attend, the MAGI East Clinical Conference is one of the fastest growing events in the clinical research industry. The conference offers an exceptional networking environment with more than 90 sessions and workshops as well as over 20 continuing contact hours and CIP (Clinical Research Contract Professional) certification exam administration.

About Quorum Review IRB
Quorum Review IRB is an independent ethics review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing ethics review of drug and device trials since 1992. Quorum Review IRB oversees research in accordance with U.S. and Canadian human research subject protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.
Quorum’s best-in-class IRB services and support includes 13 Board meetings each week plus expedited review, 24 hour site review turnaround, 36 hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum Review’s full service IRB offerings include full study review in the US and Canada, a specialized phase I team, and unique processes for post-approval and registry studies.

Contact
Sarah Smith
Marketing Manager
Quorum Review IRB
(206) 902-3319
ssmith(at)quorumreview(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sarah J. Smith
Quorum Review IRB
(877) 472.9883 (206) 902-3319
Email >